Datensatz

DATENSATZ AKTIONEN

Dieser Datensatz wurde verworfen!FreigabegeschichteDetailsÜbersicht

Verworfen

Zeitschriftenartikel

Increased Glucose Transport into Neurons Rescues Abeta Toxicity in Drosophila

MPG-Autoren

Niccoli, T.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Cabecinha, M.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Tillmann, A.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Kerr, F.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Wong, C. T.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Cardenes, D.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Vincent, A. J.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Bettedi, L.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Li, L.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Gronke, S.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Dols, J.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Partridge, L.
Max Planck Institute for Biology of Ageing, Max Planck Society;

Externe Ressourcen

(Kein Zugriff möglich)

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Es sind keine frei zugänglichen Volltexte in PuRe verfügbar

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Niccoli, T., Cabecinha, M., Tillmann, A., Kerr, F., Wong, C. T., Cardenes, D., et al. (2016). Increased Glucose Transport into Neurons Rescues Abeta Toxicity in Drosophila. Curr Biol, 26(17), 2291-300. doi:10.1016/j.cub.2016.07.017.

Zusammenfassung

Glucose hypometabolism is a prominent feature of the brains of patients with Alzheimer's disease (AD). Disease progression is associated with a reduction in glucose transporters in both neurons and endothelial cells of the blood-brain barrier. However, whether increasing glucose transport into either of these cell types offers therapeutic potential remains unknown. Using an adult-onset Drosophila model of Abeta (amyloid beta) toxicity, we show that genetic overexpression of a glucose transporter, specifically in neurons, rescues lifespan, behavioral phenotypes, and neuronal morphology. This amelioration of Abeta toxicity is associated with a reduction in the protein levels of the unfolded protein response (UPR) negative master regulator Grp78 and an increase in the UPR. We further demonstrate that genetic downregulation of Grp78 activity also protects against Abeta toxicity, confirming a causal effect of its alteration on AD-related pathology. Metformin, a drug that stimulates glucose uptake in cells, mimicked these effects, with a concomitant reduction in Grp78 levels and rescue of the shortened lifespan and climbing defects of Abeta-expressing flies. Our findings demonstrate a protective effect of increased neuronal uptake of glucose against Abeta toxicity and highlight Grp78 as a novel therapeutic target for the treatment of AD.